In:
Arteriosclerosis, Thrombosis, and Vascular Biology, Ovid Technologies (Wolters Kluwer Health), Vol. 26, No. 4 ( 2006-04), p. 857-863
Abstract:
We show enhanced expression of osteoprotegerin (OPG), RANK, and RANK ligand (RANKL) in clinical and experimental atherosclerosis with enhanced T-cell expression of RANKL as an important feature of unstable disease, further supporting a role for the OPG/RANKL/RANK axis in atherogenesis and plaque destabilization.
Type of Medium:
Online Resource
ISSN:
1079-5642
,
1524-4636
DOI:
10.1161/01.ATV.0000204334.48195.6a
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2006
detail.hit.zdb_id:
1494427-3
Permalink